Sachetta »

Homology Medicines shares owned by Sachetta

Quarter-by-quarter ownership of Homology Medicines shares owned by Sachetta from 13F filings

Historical chart of Sachetta investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by Sachetta consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by Sachetta

Quarter filed Position value Share count Share price at filing
2023-12-31 $1 1 1.00

More positions owned by Sachetta

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Etf (IWB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr North Amern Nat (IGE)
Ishares Tr U.s. Bas Mtl Etf (IYM)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Wisdomtree Tr Itl Hdg Qtly Div (IHDG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Mbs Etf (MBB)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Sachetta

Top funds holding Homology Medicines

5AM Venture Management
Vanguard Group
Newtyn Management
George Kaiser Family Foundation
ADAR1 Capital Management
Bank of America Corporation
Tudor Investment Corporation
Citadel Advisors
Barclays
Franklin Resources
American Investment Services
Virtu Financial
Schechter Investment Advisors
Goldman Sachs Group
Jane Street

View all funds holding Homology Medicines